Cathay Pacific pins hopes of recovery in flight capacity on vaccine

Sydney — Cathay Pacific Airways hopes a recovery in travel demand will allow it to operate closer to 50% of its prepandemic capacity later in 2021, provided there is an effective Covid-19 vaccine widely adopted in its key markets

The airline said on Monday it plans to operate about 10% of its prepandemic capacity for the remainder of 2020, with most borders remaining closed.

The airline industry has been hard hit by the coronavirus pandemic as many countries imposed travel restrictions to contain its spread. Many of the curbs still remain in place.

“Among the multiple scenarios studied, this one is already the most optimistic that we can responsibly adopt at this moment,” Cathay said in the release of its monthly traffic figures.

The airline said it assumed it would be operating well below 25% of pre-pandemic capacity in the first half of 2021 but that there would be a recovery in the second half if vaccines under development prove effective and are widely adopted in its key markets by the middle of 2021.

In September, the airline's passenger numbers fell by 98.1% compared with a year earlier, though cargo carriage was down by a smaller 36.6%.

Cathay had in June said it was reviewing its strategy in light of the travel downturn, with “tough decisions” to be announced during the fourth quarter.

The South China Morning Post reported on Monday the Cathay board was expected to back a restructuring plan this week that included staff redundancies and pay cuts, citing unnamed sources.

In response, Cathay told Reuters it declined to comment on speculation.

Singapore Airlines has announced plans to cut about 20% of positions, while Australia’s Qantas Airways has said it will cut nearly 30% of its prepandemic staff, but Cathay has so far refrained from major job cuts.

Cathay has sent about 40% of its passenger fleet to less humid locations outside Hong Kong for storage.

Reuters